Go Pro

Halozyme Therapeutics (HALO) Insider Trading & Ownership

Halozyme Therapeutics logo
$81.71 +0.87 (+1.07%)
As of 02:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Halozyme Therapeutics (NASDAQ:HALO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$24.40M
Get HALO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Halozyme Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HALO Insider Buying and Selling by Quarter

Halozyme Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/8/2026Sell1,923$79.77$153,397.71  
7/1/2026Sell1,625$76.71$124,653.75  
6/29/2026Sell7,304$75.00$547,800.00  
6/3/2026Sell10,000$69.07$690,700.00  
6/1/2026Sell1,625$66.21$107,591.25  
6/1/2026Sell20,000$67.58$1,351,600.00  
5/13/2026Sell10,000$69.19$691,900.00  
5/12/2026Sell20,000$71.75$1,435,000.00  
5/1/2026Sell1,625$63.48$103,155.00  
4/6/2026Sell10,000$63.50$635,000.00  
The SpaceX IPO Wasn't For You (Ad)

Just one mile from SpaceX's launchpad sits a small company doing something SpaceX can't - and it still trades under $7. Robert Kiyosaki calls it the 'Shadow SpaceX.' His go-to financial analyst found it before institutions moved in. That window may not stay open long.tc pixel

Access the Shadow SpaceX private dossier before institutions arrive
4/2/2026Sell20,000$64.24$1,284,800.00  
3/10/2026Sell8,857$67.64$599,087.48  
3/9/2026Sell20,000$67.80$1,356,000.00  
3/9/2026Buy$68.14$1,001 - $15,000
3/4/2026Sell10,000$70.21$702,100.00  
3/2/2026Sell20,000$69.69$1,393,800.00  
2/5/2026Sell10,000$78.64$786,400.00  
2/3/2026Sell20,000$76.12$1,522,400.00  
1/5/2026Sell2,000$70.25$140,500.00  
12/1/2025Sell829$71.60$59,356.40  
12/1/2025Sell16,569$68.92$1,141,935.48  
11/11/2025Sell20,000$69.13$1,382,600.00  
11/10/2025Sell2,000$68.48$136,960.00  
11/1/2025Sell4,263$65.19$277,904.97  
10/3/2025Sell20,000$69.03$1,380,600.00  
10/1/2025Sell2,000$75.24$150,480.00  
10/1/2025Sell20,000$75.35$1,507,000.00  
9/22/2025Sell2,227$77.95$173,594.65  
9/10/2025Sell20,000$75.71$1,514,200.00  
9/3/2025Sell20,000$74.44$1,488,800.00  
9/2/2025Sell4,000$73.68$294,720.00  
8/12/2025Sell20,000$63.51$1,270,200.00  
(Data available from 1/1/2013 forward)

HALO Insider Trading Activity - Frequently Asked Questions

2.50% of Halozyme Therapeutics stock is owned by insiders. Learn more on HALO's insider holdings.

The following insiders have sold HALO shares in the last 24 months: Bernadette Connaughton ($1,117,416.40), Cortney Caudill ($2,232,992.45), Helen Torley ($24,352,733.19), Jeffrey William Henderson ($1,378,751.04), Mahesh Krishnan ($547,800.00), Matthew L Posard ($1,127,333.70), Michael J Labarre ($3,001,001.16), and Nicole Labrosse ($1,687,794.65).

Insiders have sold a total of 543,425 Halozyme Therapeutics shares in the last 24 months for a total of $35,445,822.59 sold.

Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of Halozyme Therapeutics in the last year totaling $8,000.



This page (NASDAQ:HALO) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners